Image

A Study to Evaluate the Efficacy and Safety of Subcutaneous Tildrakizumab in Subjects With Moderate to Severe Genital Psoriasis.

Trial testing tildrakizumab for moderate to severe genital psoriasis.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is to test how well a new medicine, subcutaneous tildrakizumab, works and how safe it is for people with moderate to severe genital psoriasis. Subcutaneous means the medicine is given as a shot under the skin. Psoriasis is a skin condition that causes red, itchy patches. The study is in Phase 3, which means it is close to being ready for public use if it works well.

  • Study Length: Participation involves visits from the start at Week 0 to Week 16.
  • Eligibility: Must be 18 or older with moderate to severe genital psoriasis, and other health criteria.
  • Risks: If you have infections or certain medical conditions, this study might not be safe for you.

Participants must be able to follow all study rules and understand all risks. You need to have a test for TB (tuberculosis) done before joining. If you have a history of TB, you need to have had treatment.

Print
Study details
    Moderate to Severe Genital Psoriasis

NCT06611163

Sun Pharmaceutical Industries Limited

26 July 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.